The aim of this study was to evaluate the efficacy and safety of berberine as an adjuvant in treating antipsychotic‐associated weight gain and metabolic syndrome. Click to show full abstract
The aim of this study was to evaluate the efficacy and safety of berberine as an adjuvant in treating antipsychotic‐associated weight gain and metabolic syndrome.
               
Click one of the above tabs to view related content.